Topics and Expertise: antibiotics

Resistant bacteria meet their match with custom antibiotics

“Molecular building blocks” give antibiotics an edge over drug-resistant bacteria.

Using antibiotics to stop contamination in cell cultures changes them, study finds

The common lab practice of adding antibiotics to cell cultures to prevent contamination can actually induce genetic changes in the cells, a paper senior-authored by Nadav Ahituv, PhD, found. Ahituv is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department...

Koda-Kimble Seed Award recipients explore ‘blue-sky’ projects

Recipients of the UCSF School of Pharmacy 2017 Mary Anne Koda-Kimble Seed Award for Innovation will explore ideas ranging from possible new ways to treat obesity to new ways of accessing antibiotic-producing microbes found in soil.

Fujimori delivers 2017 Byers Award Lecture on tackling antibiotic resistance

Since Alexander Fleming discovered penicillin in 1940, countless lives have been saved by antibiotics. But their effectiveness is severely compromised by the emergence of antibiotic resistant strains of bacteria, accelerated by the over-prescription of antibiotics and their widespread use as growth...

MacDougall study finds severe sepsis alert speeds drug delivery

Sepsis occurs when the body responds to an infection with a mix of tissue-damaging inflammation and anti-inflammatory responses. This biological storm can lead to acute organ dysfunction (severe sepsis) and dropping blood pressure that does not respond to intravenous fluids (septic shock).

Yang study demonstrates simulator to study antibiotic dosing against biofilms

Nearly every human bacterial infection—including some of the most serious, life threatening, and costly to treat—can take the form of a biofilm, in which bacteria aggregate into structured communities that enclose themselves within a secreted slime.

Ian Seiple, PhD

Associate Professor

Our research focuses on the application of modern chemical synthesis to biological challenges. Primary branches include complex molecule synthesis, reaction development, and de novo molecular design. Each project is chosen based on its fundamental scientific merit and its potential for immediate...

Label warnings, antibiotic measurements, cancer therapies, and smoking interventions take top honors at annual seminar

Studies of improved over-the-counter acetaminophen warning labels, more accurate measurements of antibiotics in hospitalized patients, therapies for metastatic breast cancer, and methods for training pharmacy personnel to help smokers quit took top honors at the Department of Clinical Pharmacy’s...

Fischbach receives Packard Fellowship

Michael Fischbach, PhD, who studies drug-like molecules produced by human gut bacteria, has been awarded one the 16 prestigious 2011 Packard Fellowships in Science and Engineering.

Fischbach and Desai focus on “micro” solutions to improve health with drugs

Faculty members in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, share their research on the human microbiome and microfabricated drug delivery systems and their hopes for how their science will improve the health of patients.

Pages